These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 13743457)

  • 1. On the role of monoamine oxidase for the inactivation of dopamine in brain.
    ROSENGREN E
    Acta Physiol Scand; 1960 Aug; 49():370-5. PubMed ID: 13743457
    [No Abstract]   [Full Text] [Related]  

  • 2. DISTRIBUTION OF CATECHOLAMINES AND THEIR METABOLITES IN RABBIT BRAIN.
    MATSUOKA M; YOSHIDA H; IMAIZUMI R
    Biochim Biophys Acta; 1964 Feb; 82():439-41. PubMed ID: 14123587
    [No Abstract]   [Full Text] [Related]  

  • 3. Abnormal catecholamine metabolism in pheochromocytoma.
    Rubio MC; Barontini MB
    Medicina (B Aires); 1985; 45(6):631-6. PubMed ID: 2878347
    [No Abstract]   [Full Text] [Related]  

  • 4. The distribution of monoamine oxidase and succinic oxidase in brain.
    WEINER N
    Proj Rep USAF Sch Aviat Med; 1960 Jun; 60(65):1-7. PubMed ID: 24545966
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of ascorbic acid deficiency on brain catecholamines and monoamine oxidases.
    Bharaj BS; Nduati SN; Telang BV
    Indian J Physiol Pharmacol; 1980; 24(3):251-3. PubMed ID: 7461810
    [No Abstract]   [Full Text] [Related]  

  • 6. [Monoamine oxidase and its inhibitors. Physiological, physiopathological and pharmacotherapeutic considerations].
    Constantinescu I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1978; 23(4):303-12. PubMed ID: 370952
    [No Abstract]   [Full Text] [Related]  

  • 7. An isolation method of catecholamine and effect of reserpine on the enzyme systems related to the formation and inactivation of catecholamines in brain.
    ITOH T; MATSUOKA M; NAKAZIMA K; TAGAWA K; IMAIZUMI R
    Jpn J Pharmacol; 1962 Dec; 12():130-6. PubMed ID: 13957035
    [No Abstract]   [Full Text] [Related]  

  • 8. [Catecholamines: synthesis, metabolism and effects].
    Nicolau W; de Assis LM
    Rev Hosp Clin Fac Med Sao Paulo; 1970; 25(2):105-22. PubMed ID: 4938855
    [No Abstract]   [Full Text] [Related]  

  • 9. [Histochemistry of monoamine metabolism].
    Shimizu N
    Shinkei Kenkyu No Shimpo; 1968 Dec; 12(4):851-8. PubMed ID: 4898005
    [No Abstract]   [Full Text] [Related]  

  • 10. Activity of monoamine oxidase in relation to the 5-hydroxytrypatamine and norepinephrine content of the rat brain.
    GEY KF; PLETSCHER A
    J Neurochem; 1961 Feb; 6():239-43. PubMed ID: 13704855
    [No Abstract]   [Full Text] [Related]  

  • 11. The relationship between enzyme activity and the catecholamine content and secretion of pheochromocytomas.
    Feldman JM; Blalock JA; Zern RT; Wells SA
    J Clin Endocrinol Metab; 1979 Sep; 49(3):445-51. PubMed ID: 468978
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulation of catecholamine turnover by variations of enzyme levels.
    Pletscher A
    Pharmacol Rev; 1972 Jun; 24(2):225-32. PubMed ID: 4404611
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of electroconvulsive therapy on brain amine oxidase.
    SPILMAN EL; BADAL DW
    AMA Arch Gen Psychiatry; 1960 May; 2():545-7. PubMed ID: 13833351
    [No Abstract]   [Full Text] [Related]  

  • 14. [The monoamines in molluscs. I. Catecholamines: biosynthesis, disposition and inactivation (author's transl)].
    Cardot J
    J Physiol (Paris); 1979; 75(7):689-713. PubMed ID: 44729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical pharmacology of catecholamines and its clinical implications.
    Axelrod J
    Trans Am Neurol Assoc; 1971; 96():179-86. PubMed ID: 4400652
    [No Abstract]   [Full Text] [Related]  

  • 16. Application of steady-state kinetics to the study of catecholamine turnover after monoamine oxidase inhibition or reserpine administration.
    Neff NH; Costa E
    J Pharmacol Exp Ther; 1968 Mar; 160(1):40-7. PubMed ID: 5639109
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effect of methylene blue on monoamine oxidase and the catechol amine and 5-hydroxytryptamine metabolism of the brain].
    EHRINGER H; HORNYKIEWICZ O; LECHNER K
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1961; 241():568-82. PubMed ID: 13726011
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dopamine metabolism in the rabbit caudate nucleus following partial inhibition of brain monoamine oxidase by nialamide].
    Lisch HJ; Aigner A; Hornykiewicz O
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 261(4):289-98. PubMed ID: 4235430
    [No Abstract]   [Full Text] [Related]  

  • 19. Implications of catecholamine systems of the brain in schizophrenia.
    Matthysse S
    Res Publ Assoc Res Nerv Ment Dis; 1974; 53():305-15. PubMed ID: 4155111
    [No Abstract]   [Full Text] [Related]  

  • 20. Changes relevant to catecholamine metabolism in liver and brain of ascorbic acid deficient guinea-pigs.
    Deana R; Bharaj BS; Verjee ZH; Galzigna L
    Int J Vitam Nutr Res; 1975; 45(2):175-82. PubMed ID: 809379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.